Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study

Table 4 Clinical outcomes after transplantation

	Unmatched Cohort (n = 237)			Matched Cohort (n = 135)^b
	Intervention (n = 54)	Control (n = 183)	p value^a	Intervention (n = 46)	Control (n = 89)	p value^a
Related to the procedure
2003Any complication	25 / 53 (47.2)	99 / 183 (54.1)	0.373	21 / 45 (46.7)	44 / 89 (49.4)	0.761
Upper digestive hemorrhage	10 / 53 (18.9)	54 / 174 (31.0)	0.084	10 / 45 (22.2)	27 / 84 (32.1)	0.235
Arterial thrombosis	1 / 53 (1.9)	6 / 172 (3.5)	0.557	1 / 45 (2.2)	2 / 82 (2.4)	0.938
General
Duration of mechanical ventilation	0.5 ± 1.1	1.1 ± 3.9	0.242	0.5 ± 1.2	0.9 ± 1.4	0.110
Survivors	0.4 ± 1.1	0.8 ± 1.2	0.052	0.4 ± 1.1	0.8 ± 1.4	0.094
ICU length of stay	3.2 ± 4.0	4.2 ± 6.6	0.290	3.4 ± 4.3	3.6 ± 4.6	0.781
Survivors	2.8 ± 2.7	3.6 ± 5.3	0.306	2.9 ± 2.9	3.5 ± 4.6	0.463
Hospital length of stay	12.1 ± 8.9	17.2 ± 15.4	0.022	12.4 ± 9.5	16.1 ± 16.6	0.172
Survivors	11.3 ± 7.2	16.3 ± 12.7	0.007	11.6 ± 7.5	15.1 ± 11.4	0.066
In-hospital mortality	1 / 53 (1.9)	11 / 182 (6.0)	0.226	1 / 45 (2.2)	5 / 89 (5.6)	0.369

ICU: intensive care unit
Data presented as mean ± standard deviation or number / total (percentage)
^aComparison of differences between the two groups using the t test for continuous variables and the χ2 test for categorical variables
^bAdjusted by age, Child, MELD, presence of HCC and pre-transplantation hemoglobin

ISSN: 1471-2253